Company Overview

Development Stage

About the Company

赛诺菲(中国)投资有限公司四川分公司,成立于2018-04-20,位于中国(四川)自由贸易试验区成都高新区天府大道北段1199号3栋38楼3801、3802-1及39楼3901、3902、3903、3904、3905、3906号,所属行业是金融业。制药 生物技术 医药流通 100-499人

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (17 open positions)

Manage
Note: How fast is hiring at 赛诺菲(中国)投资有限公司四川分公司 growing? 2026: 36 openings (down 16%), 2025: 43 openings (up 617%), 2024: 6 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
Flat
Growth Rate
2026 vs 2025
Master's Hiring by Year: 2026 — same as 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 赛诺菲(中国)投资有限公司四川分公司 growing? Master's recruitment over the years: 2026: 3 openings (down 16%), 2025: 3 openings (up 617%).

— What Are the Salaries Like? (44 records)

Manage
salary range: 2K - 50K, 81.8% of roles pay ¥10-30K
Note: salary statistics are based on 44 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 赛诺菲(中国)投资有限公司四川分公司?81.8% of positions earn 10-30K, Undergraduate salary: ¥。Chengdu salary ranking: #729,销售类 average salary ¥15.2K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at 赛诺菲(中国)投资有限公司四川分公司? We provide: 医药代表,te,ie,ma,pe,销售,cs,ea,ee,pa,pr,analyst,dm,gh,ir,ka,od,planner,pm,sourcing. Click to view detailed salary analysis by job.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 销售类
    47.7% of total 47.7%
  • 工厂生产类
    20.5% of total 20.5%
  • 其他类
    15.9% of total 15.9%
  • 电子/电器/通信技术类
    13.6% of total 13.6%

Education

  • 本科
    61.4% of total 61.4%
  • 大专
    27.3% of total 27.3%
  • 硕士
    9.1% of total 9.1%
  • 博士
    2.3% of total 2.3%

Experience

  • 1-3年
    45.5% of total 45.5%
  • 5-10年
    29.5% of total 29.5%
  • 3-5年
    22.7% of total 22.7%
  • 不限
    2.3% of total 2.3%
View Detailed Analysis

What does 赛诺菲(中国)投资有限公司四川分公司 require? Who is 赛诺菲(中国)投资有限公司四川分公司 hiring? recruitment: 销售类占比最多占47.7%,其次是工厂生产类占20.5%. What education can get in at ? 本科占比最多占61.4%,其次是大专占27.3%. High education required at ? 硕士占9.1%,博士占2.3%. Work experience required at ? 1-3年占比最多占45.5%,其次是5-10年占29.5%. Where are the job locations at ? 成都占比最多占45.5%,其次是上海占6.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Legal Representative: OXANA MONGE
Date Established:
Credit Code: 91510100MA6CDNDR6F
Registered Address: 中国(四川)自由贸易试验区成都高新区天府大道北段1199号3栋38楼3801、3802-1及39楼3901、3902、3903、3904、3905、3906号

People who follow this company also follow

Competitors (Similar Companies)

神经系统疾病药物 研发 核酸 肿瘤学
“To develop high-quality biologics that are accessible and affordable f”
医药 生物医药 单克隆抗体药物 高通量筛选
“Research, development, and production of anti-tumor and surgical medic”
“Let everyone have trust and expectation in Baili because of health!”
“Dedicated to the research, development, production, and commercializat”
“服务药物创新、造福人类社会”
制药/药业 医药 疫苗 生物制剂
“Beauty for all”
人用疫苗 动物保健品 动物保健 罕见病
制药/药业 生物制药 兽药/兽用药品 动物健康
“A technology-driven international pharmaceutical enterprise”
代谢工程 微生物制剂 生物制剂 酶制剂
“慢病管理的有力践行者”
“Sanofi is committed to helping people address health challenges, and t”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates